P
Pooja Varshney
Researcher at University of Texas at Austin
Publications - 36
Citations - 1978
Pooja Varshney is an academic researcher from University of Texas at Austin. The author has contributed to research in topics: Medicine & Peanut allergy. The author has an hindex of 11, co-authored 25 publications receiving 1644 citations. Previous affiliations of Pooja Varshney include Duke University.
Papers
More filters
Journal ArticleDOI
A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response.
Pooja Varshney,Stacie M. Jones,Amy M. Scurlock,Tamara T. Perry,Alex R. Kemper,Pamela H. Steele,Anne Hiegel,J. Kamilaris,S.K. Carlisle,Xiaohong Yue,Mike Kulis,Laurent Pons,Brian P. Vickery,A. Wesley Burks +13 more
TL;DR: Results conclusively demonstrate that peanut OIT induces desensitization and concurrent immune modulation and causes long-term immune tolerance in children ages 1 to 16 years with peanut allergy.
Journal ArticleDOI
AR101 Oral Immunotherapy for Peanut Allergy
Brian P. Vickery,Andrea Vereda,Thomas B. Casale,Kirsten Beyer,George Du Toit,Jonathan O'b Hourihane,Stacie M. Jones,Stacie M. Jones,Wayne G. Shreffler,Annette Marcantonio,Rezi Zawadzki,Lawrence Sher,W. Carr,Stanley Fineman,Leon Greos,Rima Rachid,M Dolores Ibáñez,Stephen A. Tilles,Amal Assa'ad,Caroline Nilsson,Ned Rupp,Michael J Welch,Gordon Sussman,Sharon Chinthrajah,Katharina Blumchen,Ellen Sher,Jonathan M. Spergel,Frederick E Leickly,Stefan Zielen,Julie Wang,Georgiana M Sanders,Robert A. Wood,Amarjit Cheema,Carsten Bindslev-Jensen,Stephanie A. Leonard,Rita Kachru,Douglas T Johnston,Frank C Hampel,Edwin H. Kim,Aikaterini Anagnostou,Jacqueline A. Pongracic,Moshe Ben-Shoshan,Hemant P Sharma,Allan Stillerman,Hugh H Windom,William H. Yang,Antonella Muraro,José Manuel Zubeldia,Vibha Sharma,Morna J. Dorsey,Hey Chong,Jason A. Ohayon,J. Andrew Bird,Tara F. Carr,Dareen Siri,Montserrat Fernandez-Rivas,David K Jeong,David Fleischer,Jay A. Lieberman,Anthony E.J. Dubois,Marina Tsoumani,Christina E. Ciaccio,Jay M. Portnoy,Lyndon E Mansfield,Stephen B Fritz,Bruce J. Lanser,Jonathan Matz,Hanneke N G Oude Elberink,Pooja Varshney,Stephen G Dilly,Daniel C. Adelman,A. Wesley Burks +71 more
TL;DR: Treatment with AR101 resulted in higher doses of peanut protein that could be ingested without dose‐limiting symptoms and in lower symptom severity during peanut exposure at the exit food challenge than placebo, in this phase 3 trial of oral immunotherapy in children and adolescents who were highly allergic to peanut.
Iconographies supplémentaires de l'article : A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response
Pooja Varshney,Stacie M. Jones,Amy M. Scurlock,Tamara T. Perry,Alex R. Kemper,Pamela H. Steele,Anne Hiegel,J. Kamilaris,S.K. Carlisle,Xiaohong Yue,Mike Kulis,Laurent Pons,Brian P. Vickery,A. Wesley Burks +13 more
Journal ArticleDOI
Adverse reactions during peanut oral immunotherapy home dosing
Pooja Varshney,Pamela H. Steele,Brian P. Vickery,J. Andrew Bird,A. Thyagarajan,Amy M. Scurlock,Tamara T. Perry,Stacie M. Jones,A. Wesley Burks +8 more
TL;DR: It is observed that dosing during febrile illnesses has been associated with systemic reactions to previously tolerated peanut OIT doses, and subjects are advised to resume dosing at home if fewer than three doses are missed, and to withholding OIT during acute illnesses.
Journal ArticleDOI
Peanut oral immunotherapy is not ready for clinical use.
A. Thyagarajan,Pooja Varshney,Stacie M. Jones,Scott H. Sicherer,Robert J. Wood,Brian P. Vickery,Hugh A. Sampson,A. Wesley Burks +7 more
TL;DR: Peanut OIT has shown promise as a potential treatment for food allergy, but there remain numerous unanswered questions surrounding this investigational treatment, including the risks of OIT compared to avoidance, dosing regimen issues, patient selection, post-desensitization strategy, allocation of clinical resources, and reimbursement.